Share-Based Payment (Tables)

12 Months Ended

Jun. 30, 2025

Share-Based Payment [Abstract]

Schedule of Assumptions Used to Value the Company's Stock Options Grants

The assumptions used to value the Company’s stock options grants were as follows:

	2025			2024			2023
Expected volatility		41	%		42	%		43	%
Risk-free interest rate		4.13	%		4.42	%		4.00	%
Exercise multiples		2.2~2.8			2.2~2.8			2.2~2.8
Expected dividend yield		9	%		-	%		-	%
Forfeited rates		15~19	%		12~30	%		16~23	%
Fair market value per common share		0.81			0.98			1.135

Schedule of Stock Options Activities

The following table sets forth the summary of stock options activities:

	Number of stock options			Weighted Average Exercise Price		Weighted Average Grant-date Fair Value		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Outstanding as of July 1, 2024		6,372,427			1.93		0.92		2.3 years		175,494
Granted		1,472,000			0.81		0.16		-		-
Exercised		(313,736	)		0.80		-		-		(40,786	)
Forfeited or expired		(1,081,873	)		2.34		0.94		-		-
Outstanding as of June 30, 2025		6,448,818			1.66		0.75		2.0 years		401,095
Outstanding and exercisable as of June 30, 2025		2,698,895			2.25		1.06		-		52,913
Vested and expected to vest as of June 30, 2025		5,610,358			1.43		0.18		2.0 years		403,476

Schedule of RSU Activities

The following table sets forth the summary of RSUs activities:

	Number of Shares			Weighted- Average Grant Date Fair Value
Outstanding as of July 1, 2024		60,600			3.02
Granted		2,200,000			0.81
Vested		(2,219,300	)		0.83
Forfeited or expired		-			-
Outstanding as of June 30, 2025		41,300			2.96

Schedule of Share-Based Compensation Expense

The following table summarizes the total share-based compensation expense recognized by the Company:

	2025		2024		2023
General and administrative expenses		2,280,470		2,880,987		2,333,023
Selling and marketing expenses		179,938		275,562		129,060
Cost of revenue		7,503		11,467		16,212
Total		2,467,911		3,168,016		2,478,295